147 related articles for article (PubMed ID: 33680940)
1. Hypofractionated Radiotherapy in African Cancer Centers.
Swanson W; Kamwa F; Samba R; Ige T; Lasebikan N; Mallum A; Ngoma T; Sajo E; Elzawawy A; Incrocci L; Ngwa W
Front Oncol; 2020; 10():618641. PubMed ID: 33680940
[TBL] [Abstract][Full Text] [Related]
2. Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa.
Swanson W; Samba RN; Lavelle M; Elzawawy A; Sajo E; Ngwa W; Incrocci L
Front Oncol; 2021; 11():725103. PubMed ID: 34926247
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe - Results from an international survey.
Ratosa I; Chirilă ME; Steinacher M; Kozma E; Vojtíšek R; Franco P; Poortmans P
Radiother Oncol; 2021 Feb; 155():17-26. PubMed ID: 33065187
[TBL] [Abstract][Full Text] [Related]
4. Use of Adjuvant Breast Hypofractionation Radiation Treatment at a Cancer Center in Ontario From 2011 to 2018.
Lam E; Chan S; Karam I; Lee J; Wong G; Zhang L; Vesprini D; Wronski M; Chin L; Razvi Y; McKenzie E; Rakovitch E; Chow E
Clin Breast Cancer; 2020 Oct; 20(5):e612-e617. PubMed ID: 32321680
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
Ritter AR; Prasad RN; Jhawar SR; Bazan JG; Gokun Y; Vudatala S; Diaz DA
Am J Clin Oncol; 2024 Jun; ():. PubMed ID: 38907597
[TBL] [Abstract][Full Text] [Related]
6. Strategies to Maximize Available Resources With Minimum Cost Escalation for Improving Radiation Therapy Accessibility in the Post-Coronavirus Disease 2019 Era: An Analysis for Asia.
Datta NR; Datta S; Samiei M
Adv Radiat Oncol; 2021; 6(1):100565. PubMed ID: 32995668
[TBL] [Abstract][Full Text] [Related]
7. Fractionation in adjuvant radiotherapy for invasive breast cancer and ductal carcinoma in situ in Ontario, Canada from 2009 to 2015.
Chan S; Sutradhar R; Yao Z; Chow E; Lee J; Wan BA; Paszat L
Breast J; 2020 Apr; 26(4):602-616. PubMed ID: 31515910
[TBL] [Abstract][Full Text] [Related]
8. Choosing Wisely in radiation therapy for breast cancer: Time lag in adoption of hypofractionated radiation therapy in Victoria.
Ong WL; Khor R; Chao M; Milne RL; Millar J; Foroudi F
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):224-232. PubMed ID: 33591610
[TBL] [Abstract][Full Text] [Related]
9. Cost containment analysis and access to treatment associated with adopting hypofractionated radiation therapy from the Brazilian perspective.
Taylor P; Castilho MS; Marta GN
Lancet Reg Health Am; 2022 Sep; 13():100292. PubMed ID: 36777322
[TBL] [Abstract][Full Text] [Related]
10. Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Gastrointest Oncol; 2018 Aug; 9(4):601-609. PubMed ID: 30151256
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer.
Tovanabutra C; Katanyoo K; Uber P; Chomprasert K; Sukauichai S
Asian Pac J Cancer Prev; 2020 Jan; 21(1):119-125. PubMed ID: 31983173
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy.
McClelland S; Burney HN; Zellars RC; Ohri N; Rhome RM
Clin Breast Cancer; 2020 Dec; 20(6):469-479. PubMed ID: 32693964
[TBL] [Abstract][Full Text] [Related]
13. Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trial.
Olatunji E; Swanson W; Patel S; Adeneye SO; Aina-Tofolari F; Avery S; Kisukari JD; Graef K; Huq S; Jeraj R; Joseph AO; Lehmann J; Li H; Mallum A; Mkhize T; Ngoma TA; Studen A; Wijesooriya K; Incrocci L; Ngwa W
Ecancermedicalscience; 2023; 17():1508. PubMed ID: 37113724
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated vs. conventional radiation therapy for stage III non-small cell lung cancer treated without chemotherapy.
Iocolano M; Wild AT; Hannum M; Zhang Z; Simone CB; Gelblum D; Wu AJ; Rimner A; Shepherd AF
Acta Oncol; 2020 Feb; 59(2):164-170. PubMed ID: 31608751
[No Abstract] [Full Text] [Related]
15. Expanding radiotherapy access in Sub-Saharan Africa: an analysis of travel burdens and patient-related benefits of hypofractionation.
Patel S; Olatunji E; Mallum A; Benjika BB; Joseph AO; Joseph S; Lasebikan N; Mahuna H; Ngoma M; Ngoma TA; Nnko G; Onwualu C; Vorster M; Ngwa W
Front Oncol; 2023; 13():1136357. PubMed ID: 37143940
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings.
Starling MTM; Thibodeau S; de Sousa CFPM; Restini FCF; Viani GA; Gouveia AG; Mendez LC; Marta GN; Moraes FY
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339290
[TBL] [Abstract][Full Text] [Related]
17. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
18. Can the Adoption of Hypofractionation Guidelines Expand Global Radiotherapy Access? An Analysis for Breast and Prostate Radiotherapy.
Irabor OC; Swanson W; Shaukat F; Wirtz J; Mallum AA; Ngoma T; Elzawawy A; Nguyen P; Incrocci L; Ngwa W
JCO Glob Oncol; 2020 Apr; 6():667-678. PubMed ID: 32343628
[TBL] [Abstract][Full Text] [Related]
19. Impact of Peer Review on Use of Hypofractionated Regimens for Early-Stage Breast Cancer for Patients at a Tertiary Care Academic Medical Center and Its Community-Based Affiliates.
Ganju RG; TenNapel M; Chen AM; Mitchell M
J Oncol Pract; 2019 Feb; 15(2):e153-e161. PubMed ID: 30625021
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated radiation treatment following mastectomy in early breast cancer: the Christchurch experience.
Ko DH; Norriss A; Harrington CR; Robinson BA; James ML
J Med Imaging Radiat Oncol; 2015 Apr; 59(2):243-7. PubMed ID: 25287654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
